# Patient-Reported Outcome Questionnaire for Systemic Mastocytosis

> **NCT02380222** · — · COMPLETED · sponsor: **Adelphi Values LLC** · enrollment: 5 (actual)

## Conditions studied

- Aggressive Systemic Mastocytosis (ASM)
- SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD)
- Mast Cell Leukemia (MCL)
- Smoldering Systemic Mastocytosis (SSM)
- Indolent Systemic Mastocytosis (ISM) ISM Subgroup Fully Recruited

## Interventions

- **OTHER:** Interview

## Key facts

- **NCT ID:** NCT02380222
- **Lead sponsor:** Adelphi Values LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02380222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02380222, "Patient-Reported Outcome Questionnaire for Systemic Mastocytosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02380222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*